解开神经可塑性的细胞和分子线程:对阿尔茨海默氏症疾病病原体的洞察
Palak Kalra1, Amarjot Kaur Grewal2, Heena Khan2
1Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India; University School of Pharmaceutical Sciences, Rayat Bahra University, Mohali, Punjab 140103, India.
Neuroscience
|February 19, 2025
概括
阿尔茨海默病涉及粉样β和陶的积累,损害大脑功能. 增强神经可塑性,就像突触可塑性和神经生成一样,为阿尔茨海默病提供了一个有前途的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 老年病的医生 老年病的医生
背景情况:
- 阿尔茨海默氏症 (AD) 是老年人认知能力下降的主要原因,其特征是粉样β和病理.
- 突触功能障碍越来越被认为是AD病变和认知障碍的关键因素.
- 目前对阿尔茨海默病的治疗方法仍然不足以阻止疾病的进展或完全恢复功能.
研究的目的:
- 在阿尔茨海默病的背景下,审查神经可塑性背后的细胞和分子机制.
- 确定促进神经元存活和恢复可塑性的治疗点,以在阿尔茨海默病中恢复功能.
主要方法:
- 关于神经可塑性涉及的细胞和分子通路的文献综述.
- 治疗点的分析,包括受体,信号通路,离子通道,输送器,酶和神经变因子.
主要成果:
- 神经可塑性,包括突触可塑性和神经发生,是缓解AD相关认知缺陷的可行策略.
- 通过各种分子点恢复神经元的生存和可塑性,可以导致功能性改善.
结论:
- 准神经可塑性为阿尔茨海默病提供了一个有前途的治疗途径.
- 旨在增强突触可塑性和神经发生的干预措施可以改善AD症状和进展.
关键词:
AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD ADD was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was离子通道的离子通道有限公司 LTD.在 LTP LTP 中.神经可塑性 神经可塑性神经缩因子的神经缩因子接收器 接收器 接收器相关概念视频
Alzheimer's Disease: Overview
429
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
429
Neuroplasticity
268
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
268
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Alzheimer's Disease: Treatment
150
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
150
Role of Neurotransmitters in Memory
390
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
390
Aging
35
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
35


